John Hancock Life Insurance Fit Review for Marijuana Users

Research Snapshot

Why John Hancock Qualified for This Study

Questions This Section Answers

• Is John Hancock a good choice for life insurance if I use marijuana?
• Why did only two AI platforms name John Hancock for marijuana users?
• Does John Hancock publicly acknowledge marijuana use in its underwriting?

John Hancock qualified because it is a mainstream U.S. carrier that publicly addresses marijuana disclosure and offers term and permanent products with a wellness program, but it qualified narrowly. Only two of seven platforms named it during ranking discovery, giving it a 28.6% platform share and a final rank of 10th. Grok placed it 4th; kimi placed it 9th.

The strongest qualification signal is that John Hancock's own consumer material states that tobacco, nicotine, and marijuana use should be disclosed during life insurance underwriting, and that applications, medical records, prescription histories, and testing may be used to evaluate risk ^[1]. That is company-owned evidence, not independent verification.

Platform fit ratings diverged: openai, grok, kimi, and google rated it "good"; anthropic and deepseek rated it "uncertain"; perplexity rated it "mixed." That spread is itself the finding — the platforms agreed John Hancock is relevant, but not on how favorable it is.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Marijuana Users

Questions This Section Answers

• Which John Hancock policy should a marijuana user choose: term, UL, IUL, or whole life?
• Does John Hancock offer whole life insurance with the Vitality program for marijuana users?
• Is John Hancock's Vitality program available on term life policies for marijuana users?

The most relevant offering is John Hancock's term and permanent life insurance with the Vitality program, not a marijuana-specific product. No marijuana-specific product line was identified by any platform ^[2].

Platforms listed the relevant products as term life (10, 15, 20, 30 years), universal life (Protection UL, UL-G), and indexed universal life (Protection IUL, Accumulation IUL), with Vitality features ^[3]. John Hancock's own IUL consumer guide describes Protection IUL, Accumulation IUL, survivorship IUL, cash-value potential, and Vitality ^[5].

One material conflict: several platforms listed "whole life with Vitality," but independent reviews state John Hancock does not offer traditional whole life insurance, only universal life variants ^[6]. The openai research brief flagged this directly, noting that reviewed public pages provided clearer documentation for term, UL, IUL, and Vitality than for a marijuana-specific whole-life offering. Buyers should treat "whole life" as unconfirmed and verify product availability by state.

What the AI Platforms Agreed About

Questions This Section Answers

• Do all AI platforms agree that John Hancock requires marijuana disclosure?
• Is John Hancock's Vitality program relevant to marijuana users shopping for life insurance?
• Do AI platforms agree that John Hancock's marijuana underwriting rules are publicly documented?

Platforms agreed on three points, and disagreed on almost everything else.

Agreement 1: Disclosure is required. John Hancock states that any tobacco, nicotine, or marijuana usage should be disclosed for insurance purposes ^[8]. This is unanimous across every platform that addressed the question, and it is company-owned evidence.

Agreement 2: Vitality exists and can offset costs. John Hancock publicly promotes Vitality in connection with life insurance ^[12], and company materials describe rewards, eligibility requirements, product and state variation, and the possibility of premium savings or enhanced death benefits ^[13]. Reported savings figures range from 15% to 25% across sources ^[14].

Agreement 3: Public marijuana underwriting detail is thin. No platform retrieved a current, official, consumer-facing John Hancock marijuana rate schedule. Deepseek stated plainly that no John Hancock-published document reviewed states its current underwriting treatment of marijuana use ^[17]. Perplexity reached the same conclusion ^[18].

Agreement among AI platforms does not establish product quality or underwriting outcomes. It establishes only what the platforms reported.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Does John Hancock automatically decline marijuana users, or does it underwrite them case by case?
• How much more expensive is John Hancock for a marijuana user compared with other carriers?
• Are John Hancock's marijuana rate classes based on frequency, method of use, or THC lab results?

The disagreement is severe and unresolved.

Approval versus decline. One April 2026 independent source states John Hancock "has written cannabis-friendly guidelines" ^[21]. A separate independent source states John Hancock "will automatically decline an application if you use cannabis—regardless of your reason, situation, OR prescription" ^[23]. A 2019 industry assessment said marijuana users are "unlikely to get competitive rates" ^[24]. These claims cannot all be true, and no current official John Hancock document was retrieved to resolve the conflict.

Rate class thresholds. Grok reported detailed frequency tiers: Super Preferred Non-Smoker for use at or below once per month, Preferred Smoker up to twice weekly, Standard Smoker up to four times weekly, and individual consideration or decline for daily use ^[25]. Google reported different thresholds: Preferred Non-Smoker up to four times per month, Standard Non-Smoker for one to four days per week, and Table 2 for more than 16 days per month ^[27]. Kimi reported Standard Plus as typical for regular users ^[29]. These are three different grids from three platforms, none confirmed as current official carrier material.

Price. One comparative example cited John Hancock at $286 per month versus $49 per month for a competitor for a marijuana user ^[30]. Separately, John Hancock base term rates for nonsmokers were reported as 40–43% below the national average ^[31]. Both can be true — competitive base rates and uncompetitive marijuana classification — but no platform produced a current, verified marijuana-user quote.

Product naming. Platforms listed whole life; independent reviews say John Hancock does not offer traditional whole life ^[32].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• How does John Hancock treat smoked marijuana versus edibles or vaping in underwriting?
• Does John Hancock treat medical marijuana differently from recreational marijuana?
• Can a positive THC test change a John Hancock marijuana applicant's rate class?

The features most relevant to marijuana users are disclosure requirements, frequency-and-method differentiation, medical-versus-recreational treatment, and Vitality.

Frequency and method. A John Hancock field underwriting guide distributed through an advisor channel lists different potential classifications for smoked or vaporized versus ingested recreational marijuana and distinguishes occasional, regular, and more-than-four-times-per-week use ^[35]. Because the accessible copy is not confirmed as the current consumer underwriting manual, these classifications should be treated as indicative, not guaranteed. John Hancock's advisor portal identifies a Field Underwriting Guide as an underwriting resource ^[36].

Medical marijuana. The same field guide indicates medicinal marijuana may be evaluated differently depending on whether it is smoked, vaporized, or ingested, and that a positive test may affect classification ^[35]. Independent guidance states underwriters examine the underlying medical condition for medical cannabis patients, and that a well-controlled condition can result in standard rates ^[37]. Google reported that medical marijuana is driven heavily by the underlying condition and general medical review ^[39].

Testing. John Hancock may use applications, medical records, prescription histories, and testing to evaluate risk ^[40]. Industry reporting states carriers commonly test for drugs and detect THC, and that THC in blood may result in smoker rates two to four times higher than non-smoker rates ^[41]. Google reported that positive THC labs result in Standard Smoker at best ^[43].

Vitality. Vitality can provide rewards, discounts, and in some products an opportunity for premium savings or enhanced death benefits; participation generally requires registration and, in most instances, completion of a Vitality Health Review ^[44]. Vitality PLUS is reported as unavailable in New York ^[45].

Total View underwriting. One independent field guide states John Hancock takes a "Total View" approach to risk assessment ^[46], which could favor applicants whose only risk factor is marijuana.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does John Hancock's Vitality rider cost per month on a term or permanent policy?
• What is the cheapest John Hancock option for a marijuana user who wants term coverage?
• What cancellation, free-look, and contestability terms apply to a John Hancock policy for a marijuana user?

No reliable individualized premium can be stated. John Hancock's public materials provide program fees but not a marijuana-specific premium table ^[47].

Vitality rider pricing. John Hancock's FAQ states Vitality PLUS costs 3% of annual premium for certain term policies, $2 per month for single-life permanent products, and $4 per month for survivorship policies ^[47]. One independent review states the Vitality PLUS rider costs $2 per month for eligible policies ^[48]. A conflict exists: some term materials describe Vitality PLUS as included, while the FAQ describes a 3% annual-premium charge for term policies with the optional rider ^[47]. Buyers should confirm which applies to their product.

Base rate context. John Hancock base term rates were reported at $9–11 per month for $100,000 of coverage for a 40-year-old nonsmoker on a 20-year term, described as 40–43% below the national average ^[49]. That figure is for nonsmokers and does not establish marijuana-user pricing.

Marijuana-user pricing. One source reported a $236–287 per month difference versus competitors for a $500,000, 20-year term for a 45-year-old male marijuana user ^[50]. Industry-wide, smoker-classified users pay roughly 200% or more above non-smoker rates ^[51].

Contract terms. Term products are reported as 10, 15, 20, or 30-year level premiums, renewable to age 94, and convertible to permanent products within the first four years without new underwriting ^[52]. Permanent products are reported as lifetime coverage to age 121 for Protection UL. A standard two-year contestability period applies, during which undisclosed marijuana use can result in claim denial ^[51]. Free-look periods run 10–30 days depending on state. Exact free-look, surrender, conversion, renewal, and cancellation provisions must be obtained from the state-specific policy contract ^[47].

Additional costs. Vitality-related products or services may have additional costs, including device installment payments, taxes, upgrade fees, or merchant-specific charges, and optional riders may carry additional premiums ^[47]. Insurance products, riders, and features may vary by state and may carry additional costs ^[54].

Best Suited For

Questions This Section Answers

• Who is John Hancock actually a good fit for among marijuana users?
• Is John Hancock worth it for an occasional marijuana user who wants term coverage?
• Should a medical marijuana user with a well-controlled condition consider John Hancock?

John Hancock is best suited to occasional or moderate marijuana users with otherwise favorable health who want term or permanent coverage and are willing to complete full underwriting.

Platforms converged on these buyer profiles:

• Occasional recreational users with favorable health who want term or permanent coverage (openai fit assessment).
• Applicants who want a carrier that publicly acknowledges marijuana use as an underwriting factor rather than requiring concealment ^[55].
• Buyers interested in Vitality rewards who will satisfy program requirements ^[56].
• Medical marijuana users with well-documented, well-controlled underlying conditions, where the condition itself is the primary underwriting focus ^[58].
• Moderate users (one to four days per week) reported as potentially qualifying for Standard Non-Smoker rates ^[59].
• Buyers who value conversion flexibility, since term policies are reported convertible to permanent coverage without new underwriting within the first four years ^[61].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose John Hancock for life insurance as a marijuana user?
• Is John Hancock a bad choice for a daily marijuana user who wants non-smoker rates?
• Does John Hancock work for a marijuana user who wants a fully online application with no agent?

John Hancock is probably not the best fit for daily or high-frequency users, buyers seeking guaranteed preferred non-smoker treatment, or applicants who want a fully digital process.

Platforms identified these exclusion profiles:

• Daily or high-frequency users seeking guaranteed preferred non-smoker treatment ^[62].
• Applicants whose marijuana use is combined with nicotine, other substance use, impaired-driving history, psychiatric conditions, or the medical condition underlying prescribed use ^[63].
• Buyers who want the lowest possible price without comparing multiple carriers (openai fit assessment).
• Those preferring traditional whole life insurance, since John Hancock does not offer it ^[65].
• Applicants who want a full online application without agent interaction ^[67].
• New York residents seeking Vitality PLUS, which is reported unavailable in New York ^[68].
• Buyers seeking a published marijuana-friendly underwriting class or a guaranteed offer without medical underwriting (deepseek fit assessment).

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to John Hancock for a marijuana user who needs Preferred Plus rates?
• Which carrier is better than John Hancock for a daily marijuana user who needs case-by-case review?
• When should a marijuana user skip John Hancock and choose a simplified-issue or guaranteed-issue policy instead?

Another option may be better in four specific situations.

When a competitor offers a documented non-smoker classification for the buyer's exact profile. Platforms repeatedly named Prudential, Lincoln Financial, and Mutual of Omaha as potentially more competitive for marijuana users. Prudential was reported as offering Preferred Plus non-smoker rates for use up to four times per month, and Lincoln Financial for monthly or twice-weekly use ^[69]. These are platform-reported comparisons, not verified carrier quotes.

When the buyer uses marijuana daily or more than four times weekly. Openai's better-alternative guidance recommends a carrier comparison through an independent agent in this scenario. Pacific Life was named as potentially more accommodating for daily users ^[70].

When the buyer wants simplified or guaranteed-issue coverage. Buyers willing to accept lower limits, higher cost, or fewer features may find a better path outside John Hancock's fully underwritten process ^[71].

When the primary objective is lowest-cost temporary protection. A competing term carrier with a better confirmed offer may win on price alone (openai better-alternative guidance).

When the buyer is in New York and wants Vitality benefits. Vitality PLUS is reported unavailable in New York ^[72].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with John Hancock about marijuana classification before signing a contract?
• How can a marijuana user get a John Hancock pre-screen before submitting a formal application?
• What written documentation should a marijuana user request from John Hancock before applying?

Ask these before submitting an application:

1. How will John Hancock classify my marijuana use based on frequency, method, THC/CBD composition, recreational versus medical purpose, and last-use date? (openai questions)
2. Will my use receive non-smoker, smoker, standard, preferred, table-rated, individual-consideration, or declined treatment? (openai questions)
3. Will a positive THC test change the classification, and what testing method and look-back considerations apply? (openai questions)
4. How will the medical condition supporting a marijuana prescription affect underwriting? (openai questions)
5. How will nicotine, alcohol, other substances, psychiatric history, driving violations, and prescription records interact with marijuana underwriting? (openai questions)
6. Is the current marijuana guideline applicable to my exact product, state, age, face amount, and underwriting pathway? (openai questions)
7. What is the exact premium with and without Vitality, and is Vitality PLUS included, optional, or charged as a percentage or monthly rider fee? (openai questions)
8. Which Vitality rewards, premium savings, testing benefits, and device costs are available in my state and on my selected policy? (openai questions)
9. What are the policy's guaranteed premiums, cash-value assumptions, surrender charges, lapse risks, conversion rights, and rider charges? (openai questions)
10. Can an independent agent obtain an informal or anonymous underwriting pre-screen before submitting a formal application? (openai questions)
11. Does John Hancock have a written underwriting guidelines document for marijuana users available to agents or brokers? (anthropic questions)
12. Are there drug or intoxication exclusions in the proposed policy riders, particularly accidental death benefits? (kimi questions)

Final AI Consensus Verdict

John Hancock is a good but not conclusively best fit for marijuana users, and the platforms did not reach consensus on how favorable it is. Four platforms rated it good, two rated it uncertain, and one rated it mixed.

The case for John Hancock rests on three verified-by-platform facts: it publicly requires marijuana disclosure ^[73]; it offers term and permanent products with Vitality ^[77]; and platform-reported underwriting summaries indicate frequency and method differentiation ^[80].

The case against rests on unresolved conflicts: one source claims automatic decline for cannabis users ^[84] while another claims cannabis-friendly guidelines ^[85]; three platforms published three different frequency grids; and no current official marijuana rate schedule is publicly available. John Hancock's own consumer materials confirm disclosure and underwriting review but do not publish current marijuana-specific rate classes ^[73].

A buyer should obtain a pre-screen and compare multiple carriers before applying. Platform agreement does not prove underwriting outcomes.

How This Review Was Produced

This review was produced from seven AI platform research responses collected for the topic "Best Life Insurance for Marijuana Users," with a run research date of 2026-09-22. Platforms evaluated fit for all candidates; only platforms that named John Hancock during ranking discovery were counted as mentions. Two of seven platforms named it: grok (rank 4) and kimi (rank 9).

Each platform supplied its own citations, fit rating, strengths, limitations, pricing notes, and verification questions. Those inputs were consolidated without resolving conflicts. Where platforms disagreed, both positions are reported. Where a claim came from a platform without a supporting citation, it is labeled platform-reported.

The consensus index for this category is Life Insurance for Marijuana Users.

Broader context on how carriers approach high-risk and health-condition underwriting is available in the life insurance category directory.

Methodology Limitations

Several limitations materially affect this review.

No verified official marijuana underwriting document. The official-site retrieval for johnhancock.com failed with an HTTP 403 response, so no official-page excerpt was verified. The identity audit notes that official-site retrieval failed for one or more mentions and that identity details should be treated as reported but unverified.

Platform-reported research dates differ. Deepseek reported a research date of 2026-01-15, while all other platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

No-search model claims. Deepseek ran with search disabled. Its claims about John Hancock's marijuana underwriting are model-reported and require explicit verification before being treated as current facts.

Conflicting product names. Platforms listed whole life; independent reviews state John Hancock does not offer traditional whole life. This conflict was not resolved.

Conflicting rate grids. Grok, google, and kimi each published different frequency thresholds. None was confirmed as current official carrier material.

Conflicting approval claims. One source claims automatic decline; another claims cannabis-friendly guidelines. No current official document resolves this.

Stale and undated sources. Some cited underwriting guides date to 2014, 2017, 2019, and 2021. Their current applicability is unconfirmed.

Supplied URLs were not independently validated. The URLs in the Sources section were collected from platform responses and were not independently verified by the writer stage.

Citations are platform-reported evidence, not independently verified facts. No claim in this review should be treated as a confirmed carrier underwriting outcome.